Compare AKA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKA | CPIX |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 98.3M |
| IPO Year | 2021 | 2007 |
| Metric | AKA | CPIX |
|---|---|---|
| Price | $10.60 | $6.67 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | 866.0 | ★ 37.5K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | $42,010,949.00 |
| Revenue This Year | $4.92 | N/A |
| Revenue Next Year | $5.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.44 | ★ 16.75 |
| 52 Week Low | $8.42 | $1.85 |
| 52 Week High | $15.38 | $9.28 |
| Indicator | AKA | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 36.97 |
| Support Level | $10.23 | $6.27 |
| Resistance Level | $11.43 | $6.61 |
| Average True Range (ATR) | 0.35 | 0.54 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 33.82 | 5.46 |
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.